1. 13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC). (13th November 2020) Authors: Graybill, W; Mirza, M; González-Martin, A; O'Malley, D; Gaba, L; Yap, OWS; Guerra, E; Rose, PG; Baurain, J; Ghamande, S; Denys, H; Prendergast, E; Pisano, C; Follana, P; Braicu, EI; Calvert, PM; Korach, J; Li, Y; Gupta, D; Monk, BJ Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1235 Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment. (1st November 2019) Authors: Lippens, L; Van Bockstal, M; De Jaeghere, EA; Tummers, P; Makar, A; De Geyter, S; Van de Vijver, K; Hendrix, A; Vandecasteele, K; Denys, H Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P70 Description of the surgical management of patients with uterine corpus cancers in Belgium: results from a multicentric prospective observational study (EFFECT). (1st November 2019) Authors: Kakkos, A; De Geyndt, A; Silversmit, G; Bouche, G; de Jonge, E; Jacomen, G; Denys, H; Van Limbergen, E; Vandermeersch, B; Kerger, J; Vander Steichel, D; Baldewijns, M; Lauwers, E; Van Damme, N; Goffin, F; Amant, F Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗